$17.76 +0.42 (%) Endo International plc - NASDAQ

Jul. 27, 2016 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Wallace Weitz Comments on Endo International

    GuruFocus | Jan. 22, 2016 | 12:47PM EST
  2. Wallace Weitz Offers Rare Glimpse at Buys and Sells of 4th Quarter

    GuruFocus | Dec. 21, 2015 | 17:08PM EST
  3. Louis Moore Bacon Acquires More Than 1.5 Million Shares of JPMorgan Chase

    GuruFocus | Dec. 17, 2015 | 18:34PM EST
  4. Glenview's Larry Robbins Lowers Drug Manufacturers, Raises Health Care Providers

    GuruFocus | Nov. 20, 2015 | 18:26PM EST
  5. Health Care Investor Larry Robbins Sells Drug Manufacturers, Buys Providers

    GuruFocus | Nov. 20, 2015 | 18:26PM EST
  6. John Paulson Keeps Gold, Buys Drug Manufacturers in Q3

    GuruFocus | Nov. 17, 2015 | 13:13PM EST
  7. Benzinga's Top Downgrades

    Benzinga | Nov. 16, 2015 | 09:26AM EST
  8. 5 Worst Stock Ideas Of October

    Benzinga | Nov. 2, 2015 | 08:26AM EST
  9. FDA Approves BELBUCA Buccal Film for Chronic Pain Management

    Benzinga | Oct. 26, 2015 | 06:01AM EST
  10. Valeant Dives On Fraud Claim

    IBD | Oct. 21, 2015 | 19:14PM EST
  11. Valeant Dives As Short Seller Alleges Pharmacy Fraud

    IBD | Oct. 21, 2015 | 17:02PM EST
  12. Swedish Orphan Biovitrum AB Announces Approval of Xiapex by Swissmedic for Treatment of Peyronie's disease in Switzerland

    Benzinga | Oct. 16, 2015 | 04:24AM EST
  13. Benzinga's Top Initiations

    Benzinga | Oct. 9, 2015 | 09:34AM EST
  14. Worst Performing Industries For October 5, 2015

    Benzinga | Oct. 5, 2015 | 11:30AM EST
  15. Valeant Defended After Politics-Induced Sell-Off

    IBD | Sep. 29, 2015 | 12:45PM EST
  16. 10 Stocks Moving In Monday's After-Hours Session

    Benzinga | Sep. 28, 2015 | 16:47PM EST
  17. Benzinga's Top Downgrades

    Benzinga | Sep. 1, 2015 | 09:43AM EST
  18. Kyle Bass Focuses on Fuel, Pharmaceutical Stocks in Second Quarter

    GuruFocus | Aug. 24, 2015 | 19:15PM EST
  19. The Coming Drug-Patent Cliff Is Pushing This Portfolio Up

    Benzinga | Aug. 20, 2015 | 14:48PM EST
  20. Endo International Tops Q2 Estimates

    Benzinga | Aug. 10, 2015 | 08:02AM EST
  21. More Pharma Buyouts Ahead? 3 Top Stocks In Buy Range

    IBD | Aug. 3, 2015 | 18:21PM EST
  22. Mandel's Lone Pine Takes Stake in Growing Horizon Pharma

    GuruFocus | Jul. 28, 2015 | 02:14AM EST
  23. Valeant Earnings Soar On M&A, Organic Sales Growth

    IBD | Jul. 23, 2015 | 09:37AM EST
  24. Safer Pain Meds Developed

    IBD | Jul. 17, 2015 | 19:06PM EST
  25. Benzinga's Top Upgrades

    Benzinga | Jul. 17, 2015 | 09:20AM EST
  26. Painkiller Abuse Drives Drugmakers To Innovate

    IBD | Jul. 17, 2015 | 08:02AM EST
  27. Horizon Pharma Seen In Deal-Making Mode

    IBD | Jun. 26, 2015 | 12:27PM EST
  28. Dodge & Cox Buys 2 New Stocks

    GuruFocus | Jun. 11, 2015 | 00:20AM EST
  29. US Stock Futures Slip; All Eyes On Jobs Report

    Benzinga | Jun. 5, 2015 | 07:22AM EST
  30. Valeant CEO: Healthcare Sector A 'Bit Of A Bubble'

    Benzinga | May. 22, 2015 | 10:34AM EST
  31. Endo International Acquires Par Pharmaceuticals For $8 Billion

    GuruFocus | May. 21, 2015 | 10:48AM EST
  32. 7 Biotech Stocks Moving Off The UBS Healthcare Conference

    Benzinga | May. 19, 2015 | 14:16PM EST
  33. Endo Buying Generics Maker

    IBD | May. 18, 2015 | 18:54PM EST
  34. Stocks Rise Despite Greek Woes; Skyworks, Altera Jump

    IBD | May. 18, 2015 | 16:24PM EST
  35. Stocks Find Their Footing; Skyworks Nears Breakout

    IBD | May. 18, 2015 | 11:54AM EST
  36. Endo Buying Par Pharma To Become Top Generics Player

    IBD | May. 18, 2015 | 10:38AM EST
  37. Endo Pharmaceuticals Posts A Solid Q1 Earnings Report

    GuruFocus | May. 12, 2015 | 13:57PM EST
  38. Endo raises full-year outlook

    IBD | May. 11, 2015 | 18:46PM EST
  39. Actavis Offers Post-Allergan Guidance; Ligand Jumps

    IBD | May. 11, 2015 | 18:36PM EST
  40. Dow Leads Market Gains; NYSE Winners Top Losers 4-1

    IBD | May. 8, 2015 | 16:57PM EST
  41. Is The Drug Industry's Wedding Dance Nearly Finished?

    IBD | May. 1, 2015 | 16:08PM EST
  42. DepoMed Set To Grow On 'Transformative' Nucynta Deal

    IBD | Apr. 23, 2015 | 16:16PM EST
  43. Autohome, Other Foreign Stock Leaders Seen Posting Big Q1 Growth

    IBD | Apr. 13, 2015 | 17:17PM EST
  44. Weekly Insider Sells Highlight: ANTM, ENDP, QVCA, TOL

    GuruFocus | Apr. 13, 2015 | 02:25AM EST
  45. Analyst: Boston Scientific's Acquisition Is 'Strategically Sound'

    Benzinga | Mar. 3, 2015 | 16:10PM EST
  46. Benzinga's M&A Chatter for Monday March 2, 2015

    Benzinga | Mar. 2, 2015 | 19:29PM EST
  47. Endo to sell device business

    IBD | Mar. 2, 2015 | 18:45PM EST
  48. 'Merger Monday' Lives Up To Name: From NXP Semiconductors To eBay, There's At Least $20 Billon In Total Deals

    Benzinga | Mar. 2, 2015 | 13:19PM EST
  49. Endo Beats Q4 Views, Inks Boston Scientific Deal

    IBD | Mar. 2, 2015 | 11:41AM EST
  50. UPDATE: Endo Tops Q4 Views

    Benzinga | Mar. 2, 2015 | 08:44AM EST
Trading Center